Schiff Nutrition International, Inc., (NYSE:WNI), today
announced results for the fiscal 2010 first quarter.
Schiff Nutrition’s net sales were $48.6 million for the three
months ended August 31, 2009, compared to $47.8 million for the
same period in fiscal 2009. For the fiscal 2010 first quarter,
Schiff Nutrition reported net income of $4.4 million, or $0.15 per
diluted share. This compares to fiscal 2009 first quarter net
income of $3.2 million, or $0.11 per diluted share.
Bruce Wood, President and Chief Executive Officer, stated, “We
were encouraged with our first quarter results. We experienced
overall net sales growth of just under 2% in the first quarter
versus the year ago period, as strong performance on our branded
business more than offset a decline in private label sales volume.
We also registered significant improvement in operating income,
primarily due to an increase in gross profit from a more favorable
quarter over quarter product sales mix.”
Wood added, “We were solidly profitable even as the competitive
environment and economic conditions remained very challenging. Our
increasingly strong balance sheet enabled us to return to our
shareholders the $0.50 per share special dividend on August 28,
2009. We believe we are well positioned to support our brands and
compete aggressively over the long term.”
Conference Call Information
Schiff Nutrition International will hold a conference call
today, September 17, at 11 a.m. ET. The U.S. domestic access number
is 866-788-0543. International participants should dial
857-350-1681. The participant pass code is 82570532. Please call in
approximately ten minutes in advance. The conference call will be
broadcast live over the internet at http://www.schiffnutrition.com/press.asp,
and the webcast will be available through October 1, 2009. A replay
of the call will be available by dialing 888-286-8010 for domestic
callers and 617-801-6888 for international callers; enter access
code 58107928. The telephone replay will be available through
September 22, 2009.
About Schiff Nutrition
Schiff Nutrition International, Inc. develops, manufactures,
markets and distributes branded and private label vitamins,
nutritional supplements and nutrition bars in the United States and
throughout the world. To learn more about Schiff, please visit the
web site www.schiffnutrition.com.
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934 that are based
on management’s beliefs and assumptions, current expectations,
estimates, and projections. These statements are subject to known
and unknown risks and uncertainties, certain of which are beyond
the company’s ability to control or predict, and, therefore, actual
results may differ materially. Any forward-looking statements are
made pursuant to the Private Securities Litigation Reform Act of
1995 and, as such, speak only as of the date hereof. Schiff
Nutrition disclaims any obligation to update any forward-looking
statements whether as a result of new information, future events or
otherwise. You are cautioned not to place undue reliance on these
forward-looking statements.
Important factors that may cause these forward-looking
statements to be false include, but are not limited to: the level
of customer and consumer acceptance of Move Free® Advanced and
MegaRed®, the inability to gain or maintain market distribution for
MegaRed, the inability to successfully implement marketing and
spending programs behind our Move Free, MegaRed and other branded
products, the impact of raw material pricing, availability
(particularly relating to the limited number of krill oil
suppliers) and quality (particularly relating to joint care
products and ingredients from suppliers outside the United States,
including China), the mix between branded and private label
products, the inability to grow and/or maintain branded and private
label sales, the inability to enforce or protect our intellectual
property rights against infringement, the inability to achieve cost
savings and operational efficiencies, the inability to increase
operating margins and increase revenues, dependence on individual
products, dependence on individual customers, the impact of
competitive products and pricing (including private label), market
and industry conditions (including pricing, demand for products and
level of trade inventories), the impact of clinical studies
regarding our products or other nutritional supplements,
particularly relating to the joint care category, the success of
product development, the inability to obtain customer acceptance of
new product introductions, changes in laws and regulations,
litigation and government or administrative regulatory action in
the United States and internationally, including FDA enforcement
and challenges to marketing, advertising or product claims, the
inability or increased cost to comply with or maintain new good
manufacturing practices for the dietary supplement industry, the
inability or increased cost to obtain product liability and general
insurance, the uncertainty of market acceptance of new products,
adverse publicity regarding nutritional supplements and/or their
ingredients, the inability to find strategic transaction
opportunities or the inability to successfully consummate or
integrate a strategic transaction, changes in accounting standards,
and other factors indicated from time to time in the company’s SEC
reports, copies of which are available upon request from the
company’s investor relations department or may be obtained at the
SEC's web site (www.sec.gov).
These risks and uncertainties should be carefully considered before
making an investment decision with respect to shares of our common
stock.
SCHIFF NUTRITION INTERNATIONAL,
INC.
CONSOLIDATED CONDENSED STATEMENTS OF INCOME
(in thousands, except per share
amounts)
(unaudited)
Three Months Ended August 31, 2009 2008
Net sales $ 48,565 $ 47,790 Cost of goods sold 29,403
29,912 Gross profit 19,162 17,878 Operating
expenses: Selling and marketing 6,633 8,133 Other operating
expenses 5,503 4,725 Total operating expenses
12,136 12,858 Income from operations 7,026 5,020
Other income, net 36 279 Income before income
taxes 7,062 5,299 Income tax expense 2,671 2,050
Net income $ 4,391 $ 3,249 Weighted average common
shares outstanding – diluted 28,743 28,627 Net
income per share – diluted $ 0.15 $ 0.11
SCHIFF NUTRITION
INTERNATIONAL, INC. CONSOLIDATED CONDENSED BALANCE
SHEETS
(in thousands)
August 31, May 31, 2009 2009
(unaudited)
Cash and cash equivalents $ 48,720 $ 52,648
Available-for-sale securities 4,485 4,241 Receivables, net 17,211
20,716 Inventories 30,274 30,024 Other current assets 3,724
3,620 Total current assets 104,414 111,249
Property and equipment, net 13,990 13,920 Other assets, net
5,570 5,028 Total assets $ 123,974 $ 130,197
Current liabilities $ 22,015 $ 19,034
Long-term liabilities 2,312 1,470 Stockholders’ equity
99,647 109,693 Total liabilities &
stockholders’ equity $ 123,974 $ 130,197
Schiff Nutrit (NYSE:WNI)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Schiff Nutrit (NYSE:WNI)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024